| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJROBP.2005.10.007 |
| P698 | PubMed publication ID | 16580497 |
| P2093 | author name string | Peter Blake | |
| H Jervoise N Andreyev | |||
| Andrew R Norman | |||
| Kevin J Harrington | |||
| Diana Tait | |||
| Usman Khalid | |||
| Vincent S Khoo | |||
| Claire Hackett | |||
| Camilla McGough | |||
| P433 | issue | 5 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 1432-1441 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading | |
| P478 | volume | 64 |
| Q48162758 | Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial |
| Q36922615 | Clinical risk factors for late intestinal toxicity after radiotherapy: a systematic review protocol |
| Q93046461 | Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician |
| Q38412474 | Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review |
| Q33638354 | Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study) |
| Q36988575 | Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients |
| Q36534810 | Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial |
| Q60922303 | Intake of citrus fruits and vegetables and the intensity of defecation urgency syndrome among gynecological cancer survivors |
| Q49844731 | Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers |
| Q36383774 | Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy? |
| Q24185868 | Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis |
| Q88242645 | Nutritional strategies to prevent gastrointestinal toxicity during pelvic radiotherapy |
| Q48171729 | Nutritional support and parenteral nutrition in cancer patients: an expert consensus report. |
| Q37427669 | Radiation colitis and proctitis |
| Q33459118 | Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers |
| Q28304957 | Radiation-induced small bowel disease: latest developments and clinical guidance |
| Q92054869 | SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial |
| Q33457440 | Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy |
| Q93200189 | The Effects of Hyperbaric Oxygen Therapy on Pelvic Radiation Induced Gastrointestinal Complications (Rectal Bleeding, Diarrhea, and Pain): A Meta-Analysis |
| Q36534462 | The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study |
Search more.